A quarter of stroke patients have impaired tissue reperfusion with probable adverse clinical impact despite successful recanalization. 1 Culminating evidence from animal histological data on temporary middle cerebral artery (MCA) occlusion suggests microvascular obstruction as the mechanism of this no-reflow phenomenon. 1, 2 To date, clinical studies have been limited because of the lack of clinical modalities to conclusively demonstrate its presence in humans.
The Gosling pulsatility index (PI) and Pourcelot resistance index (RI) derived from routine transcranial Doppler (TCD) parameters are established indices of cerebrovascular resistance. 3 We investigate whether TCD can detect microvascular changes postrecanalization as a biomarker of the no-reflow phenomenon on acute ischemic stroke patients.
Methods
Study data are available on request from the corresponding author.
Consecutive patients between January 2013 and December 2017 with acute MCA occlusions recanalized by mechanical thrombectomy with angiographic Thrombolysis in Cerebral Infarction grade IIb/III flow within 6 hours of onset and who underwent follow-up TCD within 3 days at a Comprehensive Stroke Centre with a highvolume neurovascular laboratory (>1100 cases/yr) were retrospectively identified from a departmental thrombectomy database. At the center, TCDs were routinely performed in (1) acute ischemic stroke inpatients as a standard follow-up investigation, and (2) outpatients undergoing carotid Doppler for transient ischemic attack and carotid stenosis surveillance as an adjunct component of the center's neurosonography protocol. Age/gender-matched controls were identified among outpatients undergoing carotid Doppler TCD in the study period who had stroke excluded as a diagnostic differential after clinical and magnetic resonance imaging evaluation. Patients or controls with inadequate temporal bone windows for TCD were excluded from analysis. The institute's Ethics Committee granted ethical approval and waived informed consent requirement.
TCD transtemporal examination of bilateral MCAs (50 mm depth) was conducted using a 2-MHz handheld transducer (Compumedics DWL, Germany) by experienced sonographers. Mean-flow velocity © 2018 American Heart Association, Inc.
Background and Purpose-Impaired microvascular reperfusion despite complete recanalization (no-reflow) represents a potential therapeutic target to improve outcomes after recanalization therapies. Three comparisons of PI and RI were made. First, the mean absolute PI and RI values were compared. Second, the proportion of subjects with an asymmetrically increased PI and RI in the symptomatic MCA (ie, substantial asymmetry >20% interside differences) was compared between patients and controls. Third, the proportion of subjects with an abnormally elevated PI and RI (ie, beyond the normal reference threshold of 1.2 and 0.75, respectively 4, 5 ) was compared between the symptomatic MCA of patients and the corresponding MCA of controls.
Follow-up computed tomography and magnetic resonance imaging were reviewed by an experienced reader blinded to clinical details. Radiological outcomes assessed were manually delineated follow-up infarct volume (FIV) in milliliters and posttreatment hemorrhage defined by European Cooperative Acute Stroke Study classification.
TCD parameters were analyzed using 2-tailed Student t tests and Fisher exact test for numeric and categorical outcomes, respectively (SPSS 20.0). A P value of <0.05 was considered significant.
Results

Demographics
Fifty-three patients were identified and compared to 53 age/ gender-matched controls. The median age and presenting National Institutes of Health Stroke Scale score was 73 (interquartile range [IQR], 66-83) and 15 (IQR, 9-19). Intravenous thrombolysis was administered in 58.5% of patients. The median onset-to-groin-puncture time was 193 minutes (IQR, 154-301). Median times to follow-up TCD were 1 day (IQR, 1-2), computed tomography 1 day (IQR, 1-1), and magnetic resonance imaging 2 days (IQR, 1-3). No patients had MCA reocclusion on TCD as assessed by Thrombolysis in Brain Ischemia classification. 6 Overall, 47.6% of patients had an excellent functional outcome at 90 days (modified Rankin Scale score of ≤1). FIV on follow-up imaging was <20 mL in 52.8% of patients. The rates of hemorrhage were 24.5% for hemorrhagic infarction, 9.4% for parenchymal hemorrhage (PH), and 5.7% for symptomatic intracerebral hemorrhage. PH (P=0.005) but not hemorrhagic infarction (P=0.585) was associated with FIV. Compared with controls, patients had more atrial fibrillation (55.4% versus 13.9%; P<0.01). Cerebrovascular mimics were the commonest diagnosis in the control cohort (Table III in 
Presence of Elevated Microvascular Resistance Postrecanalization
The microvascular resistance indices PI and RI were elevated in the symptomatic MCA on all 3 comparisons. Mean symptomatic MCA-PI ( Figure 1 ). 
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Because large infarct and ICH may alter MCA-PI through increased intracranial pressure, 3, 7 we repeated the analysis among patients with minimal FIV (<20 mL, 8 n=28) and found similar results. No patients in this subgroup had PHs. Symptomatic MCA-PI and RI mean values were consistently higher on all subgroup analyses (Table IV in the online-only Data Supplement). MCA-PI of the symptomatic hemisphere remained significantly more likely to be asymmetrically increased (29.6% versus 4.17%; P=0.026) and abnormally elevated (50.0% versus 14.3%; P=0.009) when adjusting for FIV.
Significance of Elevated Microvascular Resistance
FIVs were similar between patients with and without an asymmetrically increased MCA-PI (P=0.614) or an abnormally elevated MCA-PI (P=0.248). Both indices of elevated microvascular resistance were associated with less hemorrhagic complications (Figure 2) . Patients with an abnormally elevated MCA-PI and MCA-RI value in the symptomatic hemisphere had significantly less hemorrhagic infarction (9.5% versus 45.8%; P=0.009) and peri-infarct hemorrhage of any types (0.0% versus 43.2%; P=0.037), respectively. No associations were found between elevated microvascular resistance with PH and symptomatic intracerebral hemorrhage.
Elevated microvascular resistance indices were associated with poor clinical outcome. Significantly fewer patients with an asymmetrically increased MCA-PI had an excellent functional outcome (modified Rankin Scale score of ≤1) at 90 days (18.2% versus 58.1%; P=0.035).
Discussion
We find cerebral microvascular resistance of the ischemic territory to be significantly elevated despite complete recanalization of the culprit vessel even when FIV is minimal. Our data support the analogous presence in patients and potential clinical relevance of no-reflow postrecanalization acute microvascular dysfunction that has been demonstrated in animal models.
No-reflow with persistent oligemia is a well-recognized but poorly understood phenomenon in the coronary circulation and among preclinical stroke studies. 1 Capillary dysfunction with microvascular occlusion has been suggested as the common mechanism among proposed theories including microthrombi clogging, astrocyte swelling, and pericyte constriction. The growing recognition in the importance of reperfusion as distinct from recanalization 9 has led to recent interest in the noreflow phenomenon as a potential therapeutic target to enhance treatment efficacy. However, the lack of available clinical tools to evaluate cerebral microvascular hemodynamics has limited translating experimental findings to clinical studies.
TCD for cerebral microvasculature evaluation has been increasingly applied to ischemic strokes research. Although earlier studies used TCD to assess cerebral large vessels patency post-thrombolysis, 6 recent applications have included evaluating cerebrovascular resistance by PI to predict white matter lesion burden, 10 lacunar infarct-associated cognitive impairment, 11 and malignant infarction with raised intracranial pressure. 3 Our results suggest that TCD may also be used for microvascular resistance assessment in acute stroke clinical studies to examine postrecanalization pathophysiology. As a hypothesis-generating study, our data further raise the possibility that elevated microvascular resistance after cerebral ischemia may be a maladaptive pathophysiological reaction protective of reperfusion hemorrhage but adversely associated with injury beyond radiologically defined infarct. 12 Our study has several limitations. The retrospective nature and small population require larger studies for confirmation. Variability in follow-up imaging timing and modality may have impacted on FIV measurements and hemorrhage identification. We did not control for potential confounders such as differences in preexisting small-vessel disease burden with diffusely increased cerebrovascular resistance between groups. The small number of PH in our population limits evaluation of the interaction between PI and larger hematoma mass which has been shown to elevate PI. 7 Finally, FIV topography may have contributed to functional outcome analysis.
In conclusion, we provide the first evidence of postrecanalization acute microvascular dysfunction in humans. Elevated microvascular resistance within the ischemic territory postrecanalization assessed on TCD may represent a readily obtainable and clinically relevant biomarker of the no-reflow phenomenon. Further studies evaluating the role of microvascular dysfunction in reperfusion injury with angiographic and perfusion imaging are warranted.
